Does IMRT Increase the Integral Dose to Normal Tissue for Postoperative Patients with Endometrial Cancer?

YANG Ruijie,WANG Junjie,JIANG Weijuan

DOI: https://doi.org/10.3969/j.issn.1000-8179.2009.17.002

2009-01-01

Chinese Journal of Clinical Oncology

Abstract:Objective:To investigate whether IMRT will increase the integral dose to normal tissue for postoperative patients with endometrial cancer. Methods:Computed Tomography (CT) image sets of ten postoperative endometrial cancer patients were acquired. Whole pelvic 3D-CRT and IMRT plans were created for each patient. The dose distribution of the targets, organs at risk and normal tissue were analyzed and compared across the types of plans. Results:The mean dose to PTV was 52.6 Gy and 52.6 Gy (P=0.72) for the 3D-CRT and IMRT plans, respectively. The mean homogeneity index was 1.08 and 1.10 (P=0.01), and the mean conformity index was 0.61 and 0.87 (P=0.00) for the 3D-CRT and IMRT plans, respectively. The mean integral dose to small bowel and colon, rectum, bladder and pelvic bone was reduced by 1.8 Gy-L (P=0.00), 0.5 Gy-L (P=0.00), 4.7 Gy-L (P=0.00) and 4.1 Gy-L (P=0.00), respectively, in the IMRT plans. The mean integral dose to normal tissue was also reduced by 19.2 Gy-L (P=0.00), while the V5 and V10 of normal tissue increased by 9.0% (P=0.00) and 4.0% (P=0.00), respectively, in the IMRT plans. Conclusion:IMRT plans result in more conformal dose distribution and reduce the integral dose to the small intestine and colon, rectum, bladder, pelvic bones and normal tissue, while increasing the voltwie of normal tissue irradiated to low doses compared with 3D-CRT plans.